Perfecting Placement of PARPs: Preventing Progression of Ovarian Cancer

August 25, 2021

In the fast paced world of PARP inhibitor approvals in both the setting of maintenance and therapy in ovarian cancer, this panel of experts will assist practitioners to understand how to order germline and somatic testing for BRCA and HRD mutations. Speakers will discuss sequencing of PARP inhibitors as well as mitigating side effects. Additionally, they will discuss future directions for the use of PARP inhibitors as well as briefly discuss resistance to PARP inhibitors.

Speakers:
Premal Thaker, MD, MS
Washington University in St. Louis Siteman Cancer Center

Mary (“Maggie”) Mullen, MD
Washington University in St. Louis School of Medicine

John Farley, MD, COL, FACOG, FACS
Dignity Health - Cancer Institute, St. Joseph's Hospital and Medical Center

Todd Tillmanns, MD, FACOG
West Cancer Center

Keywords: Ovarian, Ovary, PARP, PARPi, Maintenance therapy, Toxicity, future applications


This is an educational resource produced through collaboration between the Society of Gynecologic Oncology (SGO) and the Cancer Association of Community Cancer Centers (ACCC). 

     


This activity is supported by independent medical education grants from AstraZeneca and Merck.

Target Audience

Physicians, Trainees, Residents, Fellows, APPs

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
    In support of improving patient care, the Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. The Society of Gynecologic Oncology designates this virtual presentation for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation.
  • 0.50 AMA PRA Category 1 Credits™- For Non-physicians
    In support of improving patient care, the Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. PAs may claim a maximum of 0.50 Category I credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™. from organizations accredited by ACCME or a recognized state medical society. PAs should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.50 Attendance
    In support of improving patient care, the Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The Society of Gynecologic Oncology designates this virtual presentation for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation.
  • 0.50 CNE Contact Hours
    In support of improving patient care, the Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. The Society of Gynecologic Oncology designates this virtual activity for a maximum of 0.50 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Course opens: 
07/27/2021
Course expires: 
12/31/2030
Event starts: 
08/25/2021 7:00pm CDT
Event ends: 
08/25/2021 7:45pm CDT
Cost:
$0.00
Rating: 
0

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
    In support of improving patient care, the Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. The Society of Gynecologic Oncology designates this virtual presentation for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation.
  • 0.50 AMA PRA Category 1 Credits™- For Non-physicians
    In support of improving patient care, the Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. PAs may claim a maximum of 0.50 Category I credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™. from organizations accredited by ACCME or a recognized state medical society. PAs should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.50 Attendance
    In support of improving patient care, the Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The Society of Gynecologic Oncology designates this virtual presentation for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation.
  • 0.50 CNE Contact Hours
    In support of improving patient care, the Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. The Society of Gynecologic Oncology designates this virtual activity for a maximum of 0.50 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Price

Cost:
$0.00
Please login or register to take this course.